⌘K
Loading ticker…
As of 2026-08-24, Denali Therapeutics Inc. Common Stock (DNLI) has a 3-month relative strength percentile of 88 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 61. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 3.8%, relative volume 0.97×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
DNLI is held by 27 ETFs as of May 2026. Top owner: VTWO at 0.09% weight, $15M notional. Top 3 carry $39M.
Held by 63 ETFs · $467M across latest filings · largest weight 2.82% (IBRN).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.09% | $15M | — |
| SCHASchwab U.S. Small-Cap ETF | 0.07% | $15M | — |
| VHTVanguard Health Care ETF | 0.05% | $9M | — |
| AVSC | 0.16% | $4M | −0.02 pp |
| SBIO | 2.13% | $3M | +0.12 pp |
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.17% |
| $2M |
| — |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $2M | — |
| FDG | 0.34% | $1M | −0.06 pp |
| ESML | 0.05% | $1M | — |
| ONEQ | 0.01% | $1M | — |
Showing 10 of 27 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | DNLI Jan avg: 7.36% median: 11.59% win: 75% σ: 23.91% n: 4 2022-04-12 → 2026-07-31 | DNLI Feb avg: -4.57% median: -6.44% win: 25% σ: 21.76% n: 4 2022-04-12 → 2026-07-31 | DNLI Mar avg: -9.66% median: -12.24% win: 25% σ: 9.62% n: 4 2022-04-12 → 2026-07-31 | DNLI Apr avg: -3.54% median: -2.50% win: 40% σ: 19.70% n: 5 2022-04-12 → 2026-07-31 | DNLI May avg: 7.17% median: 12.39% win: 80% σ: 17.30% n: 5 2022-04-12 → 2026-07-31 | DNLI Jun avg: 14.37% median: 21.16% win: 80% σ: 12.03% n: 5 2022-04-12 → 2026-07-31 | DNLI Jul avg: 1.05% median: -1.14% win: 40% σ: 9.84% n: 5 2022-04-12 → 2026-07-31 | DNLI Aug avg: -6.69% median: -9.19% win: 50% σ: 14.50% n: 4 2022-04-12 → 2026-07-31 (current) | DNLI Sep avg: 3.64% median: 3.00% win: 50% σ: 13.81% n: 4 2022-04-12 → 2026-07-31 | DNLI Oct avg: -3.51% median: -7.64% win: 25% σ: 10.57% n: 4 2022-04-12 → 2026-07-31 | DNLI Nov avg: 6.38% median: 4.81% win: 50% σ: 11.02% n: 4 2022-04-12 → 2026-07-31 | DNLI Dec avg: -7.66% median: -14.03% win: 25% σ: 15.86% n: 4 2022-04-12 → 2026-07-31 |